Inhibitory effects of berberine on Fonsecaea monophora in vitro and in vivo.

BMC Complement Med Ther · 2025 · PMC12534958 · PMID 41107854

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Analysis showed overall, there was a highly significant difference in model group and both BBR treatment groups regarding surviving count per each group (P = < 0.001 for both the 64 μg/mL and 128 μg/mL BBR dose groups).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.